Small molecule inhibitors of Janus kinases

被引:0
作者
Feutrill, John [1 ]
Andrau, Laura [1 ]
Bourke, David G. [1 ]
Bu, Xianyong [1 ]
Bukczynska, Patricia [1 ]
Bums, Christopher [1 ]
Court, Naomi [1 ]
Donohue, Andrew [1 ]
Fantino, Emmanuelle [1 ]
Farrugia, Michelle [1 ]
Joffe, Max [1 ]
Kling, Marcel [1 ]
Kurek, Margarita [1 ]
Nero, Tracy [1 ]
Thao Nguyen [1 ]
Palmer, James T. [1 ]
Sikanyika, Harrison [1 ]
Treutlein, Herbert [1 ]
Wan, Soo San [1 ]
Wilks, Andrew [1 ]
Zeng, Jun [1 ]
机构
[1] Cytopia, Richmond, Vic 3121, Australia
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
218-MEDI
引用
收藏
页数:1
相关论文
共 50 条
[21]   Targeting ErbB tyrosine kinases with platinum-functionalized small molecule inhibitors [J].
Yang, Mu ;
Wu, Hanzhi ;
West, Tiffany ;
Furdui, Cristina ;
Kucera, Gregory ;
Bierbach, Ulrich .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[22]   ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors [J].
Roskoski, Robert, Jr. .
PHARMACOLOGICAL RESEARCH, 2014, 87 :42-59
[23]   Prediction of mutations in Plasmodium falciparum kinases in response to small molecule inhibitors. [J].
Schiebout, Michael H. ;
Keenan, Susan M. .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2008, 38 :S66-S67
[24]   Novel Small Molecule Inhibitors of Cyclin-dependent Kinases as Anticancer Agents [J].
Srivastava, Nitin ;
Saxena, Anil Kumar .
CURRENT MEDICINAL CHEMISTRY, 2025,
[25]   Characterization of small molecule inhibitors of the PIM kinases in in vitro models of hematological malignancies [J].
Sastri, Christine E. ;
Guerrero, Nadia ;
Yu, Dongyin ;
Mattson, Bethany ;
Dellamaggiore, Ken ;
Yang, Yajing ;
Hughes, Paul ;
Wang, Hui-Ling ;
Cee, Victor ;
Lanman, Brian A. ;
Pettus, Liping ;
Reed, Anthony B. ;
Wu, Bin ;
Wurz, Ryan ;
Tasker, Andrew ;
Huang, Li-Ya ;
Branstetter, Daniel ;
Rex, Karen ;
Winston, Jeffrey ;
Burgess, Teresa L. ;
Kendall, Richard ;
Lipford, J. Russell .
CANCER RESEARCH, 2015, 75
[26]   Characterization of Pim Protein Kinases and Evaluation of Small Molecule Inhibitors in Multiple Myeloma [J].
An, Ningfei ;
Im, Yeong-Bin ;
Lin, Yingwei ;
Gasparetto, Cristina ;
Costa, Luciano J. ;
Stuart, Robert K. ;
Smith, Charles ;
Kraft, Andrew ;
Kang, Yubin .
BLOOD, 2011, 118 (21) :1254-1255
[27]   Pharmacology of inhibitors of Janus kinases - Part 1: Pharmacokinetics [J].
Eichner, Adina ;
Wohlrab, Johannes .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (11) :1485-1499
[28]   Pharmacology of inhibitors of Janus kinases - Part 2: Pharmacodynamics [J].
Eichner, Adina ;
Wohlrab, Johannes .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (12) :1631-1631
[29]   Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells [J].
Laux, Julian ;
Forster, Michael ;
Riexinger, Laura ;
Schwamborn, Anna ;
Guezguez, Jamil ;
Pokoj, Christina ;
Kudolo, Mark ;
Berger, Lena M. ;
Knapp, Stefan ;
Schollmeyer, Dieter ;
Guse, Jan ;
Burnet, Michael ;
Laufer, Stefan A. .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (08) :573-602
[30]   Drug Insight: small-molecule inhibitors of protein kinases in the treatment of thyroid cancer [J].
Massimo Santoro ;
Francesca Carlomagno .
Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 :42-52